title: Alternative medicine and Alzheimer disease.
abstract: BACKGROUND
  Complimentary and alternative medicine has an extensive worldwide history and is commonly used by older patients. A number of different alternative medicines are used by patients having Alzheimer disease. It is both desirable and expected for clinicians to be acquainted with these medications.
  
  
  RESULTS
  This paper discusses the available clinical trial evidence regarding 8 agents commonly used by people having Alzheimer disease. We provide an overview of the history and basic scientific evidence available for each agent, followed by a critical analysis of the evidence available from clinical trials, including the number of participants, trial duration, and specific outcomes evaluated.
  
  
  CONCLUSIONS
  Although many of these compounds have been associated with interesting basic science, none has shown clear clinical benefit to date. Data available for some, such as Ginkgo biloba, curcumin, and huperzine A, suggest that further evaluation is warranted. Familiarity with this literature will allow clinicians to provide meaningful recommendations to patients who wish to use these agents.
authors.affiliation: From the Department of Neurology, Mayo Clinic, Rochester, Minnesota 55905, USA.
authors.forename: Brendan J
authors.initials: BJ
authors.lastname: Kelley
authors.forename: David S
authors.initials: DS
authors.lastname: Knopman
mesh_terms: D000544:Alzheimer Disease / Q000628:therapy*; D002986:Clinical Trials as Topic; D000529:Complementary Therapies / Q000145:classification / Q000379:methods*; D006801:Humans
references.citation: Neurology. 2000 Sep 26;55(6):805-10
references.pmid: 10994000
references.citation: J Am Geriatr Soc. 1989 Jun;37(6):515-20
references.pmid: 2715559
references.citation: Neurology. 1993 Jan;43(1):153-63
references.pmid: 8423880
references.citation: Zhongguo Yao Li Xue Bao. 1995 Sep;16(5):391-5
references.pmid: 8701750
references.citation: Neurology. 2006 Nov 14;67(9 Suppl 3):S6-11
references.pmid: 17101932
references.citation: Contemp Clin Trials. 2006 Jun;27(3):238-53
references.pmid: 16627007
references.citation: Cochrane Database Syst Rev. 2003;(3):CD001015
references.pmid: 12917896
references.citation: Curr Alzheimer Res. 2005 Dec;2(5):541-51
references.pmid: 16375657
references.citation: J Alzheimers Dis. 2006 Sep;10(1):1-7
references.pmid: 16988474
references.citation: Tumori. 2005 Mar-Apr;91(2):135-8
references.pmid: 15948540
references.citation: Curr Alzheimer Res. 2005 Apr;2(2):131-6
references.pmid: 15974909
references.citation: J Neurol Neurosurg Psychiatry. 2004 May;75(5):677-85
references.pmid: 15090558
references.citation: J Am Geriatr Soc. 1987 May;35(5):425-30
references.pmid: 3553281
references.citation: Lancet. 2001 Dec 1;358(9296):1885-92
references.pmid: 11741647
references.citation: Am J Health Syst Pharm. 1999 Oct 15;56(20):2038, 2043-4
references.pmid: 10541030
references.citation: Arzneimittelforschung. 2007;57(1):4-11
references.pmid: 17341003
references.citation: Neurobiol Aging. 1987 Nov-Dec;8(6):501-10
references.pmid: 3431625
references.citation: Neurology. 1993 Feb;43(2):301-5
references.pmid: 8437693
references.citation: Cochrane Database Syst Rev. 2002;(4):CD003120
references.pmid: 12519586
references.citation: J Clin Pharmacol. 2005 Sep;45(9):1048-54
references.pmid: 16100299
references.citation: Mol Psychiatry. 2000 Nov;5(6):616-32
references.pmid: 11126392
references.citation: J Gerontol A Biol Sci Med Sci. 2001 Oct;56(10):M650-5
references.pmid: 11584039
references.citation: Isr J Psychiatry Relat Sci. 2000;37(4):302-7
references.pmid: 11201936
references.citation: Eur J Pharmacol. 1991 Feb 26;194(1):11-6
references.pmid: 2060587
references.citation: Eur Neuropsychopharmacol. 1992 Jun;2(2):149-55
references.pmid: 1633433
references.citation: Sci Am. 2003 Apr;288(4):86-91
references.pmid: 12661320
references.citation: Alzheimer Dis Assoc Disord. 1995 Fall;9(3):128-31
references.pmid: 8534410
references.citation: Eur J Pharmacol. 1990 Oct 23;187(3):551-3
references.pmid: 1981558
references.citation: Psychopharmacol Bull. 1988;24(1):130-4
references.pmid: 3290936
references.citation: Int Clin Psychopharmacol. 2003 Mar;18(2):61-71
references.pmid: 12598816
references.citation: Acta Pharmacol Sin. 2006 Jan;27(1):1-26
references.pmid: 16364207
references.citation: Cochrane Database Syst Rev. 2003;(2):CD003158
references.pmid: 12804452
references.citation: J Nutr Biochem. 2004 Dec;15(12):749-56
references.pmid: 15607648
references.citation: Cochrane Database Syst Rev. 2001;(2):CD001011
references.pmid: 11405971
references.citation: Neuroreport. 1997 Mar 3;8(4):963-8
references.pmid: 9141073
references.citation: Int Clin Psychopharmacol. 1991 Spring;6(1):31-43
references.pmid: 2071888
references.citation: J Nutr. 1995 Jun;125(6):1484-9
references.pmid: 7782901
references.citation: JAMA. 1998 Nov 11;280(18):1569-75
references.pmid: 9820257
references.citation: J Gerontol A Biol Sci Med Sci. 2000 Jan;55(1):M4-9
references.pmid: 10719766
references.citation: Ann N Y Acad Sci. 2004 Dec;1035:68-84
references.pmid: 15681801
references.citation: Pharmacopsychiatry. 1999 Mar;32 Suppl 1:33-7
references.pmid: 10338106
references.citation: Arzneimittelforschung. 1992 Mar;42(3):281-3
references.pmid: 1497684
references.citation: Clin Cancer Res. 2003 Nov 15;9(15):5756-67
references.pmid: 14654561
references.citation: Curr Med Chem. 2000 Mar;7(3):355-74
references.pmid: 10637369
references.citation: Neurology. 1996 Sep;47(3):705-11
references.pmid: 8797468
references.citation: Neurosignals. 2005;14(1-2):71-82
references.pmid: 15956816
references.citation: Cochrane Database Syst Rev. 2003;(1):CD003119
references.pmid: 12535455
references.citation: Brain Res Bull. 2000 Oct;53(3):245-54
references.pmid: 11113577
references.citation: J Neurosci. 2006 Dec 13;26(50):13102-13
references.pmid: 17167099
references.citation: Eur J Cancer. 2005 Aug;41(12):1746-50
references.pmid: 16039110
references.citation: Cell Mol Life Sci. 2003 Sep;60(9):1779-92
references.pmid: 14523543
references.citation: Free Radic Biol Med. 2006 Dec 15;41(12):1781-94
references.pmid: 17157181
references.citation: J Neurosci. 2001 Nov 1;21(21):8370-7
references.pmid: 11606625
references.citation: JAMA. 1997 Oct 22-29;278(16):1327-32
references.pmid: 9343463
references.citation: Dement Geriatr Cogn Disord. 2002;13(4):217-24
references.pmid: 12006732
references.citation: J Biosci. 2001 Jun;26(2):135-43
references.pmid: 11426049
references.citation: Ann N Y Acad Sci. 2005 Aug;1053:153-61
references.pmid: 16179519
references.citation: Zhongguo Yao Li Xue Bao. 1999 Jun;20(6):486-90
references.pmid: 10678137
references.citation: J Geriatr Psychiatry Neurol. 1999 Summer;12(2):76-81
references.pmid: 10483929
references.citation: Cond Reflex. 1973 Apr-Jun;8(2):108-15
references.pmid: 4736348
references.citation: Psychopharmacol Bull. 1992;28(1):61-6
references.pmid: 1609044
references.citation: CNS Drug Rev. 2005 Summer;11(2):169-82
references.pmid: 16007238
references.citation: Appl Microbiol Biotechnol. 2004 May;64(4):465-72
references.pmid: 14740187
references.citation: J Biol Chem. 2005 Feb 18;280(7):5892-901
references.pmid: 15590663
references.citation: JAMA. 1998 Sep 2;280(9):784-7
references.pmid: 9729989
references.citation: Altern Ther Health Med. 2003 Jul-Aug;9(4):50-6
references.pmid: 12868252
references.citation: Antioxid Redox Signal. 2004 Apr;6(2):277-87
references.pmid: 15025929
references.citation: Pharmacol Res. 1996 Feb;33(2):73-80
references.pmid: 8870022